AFRY enables Vistin Pharma to double the production capacity of diabetes medicine
(WorldNews Norway)

As partner for five years of Vistin Pharma, AFRY has been entrusted to carry out a turn key project and build a plant with the purpose of doubling the production capacity of the diabetes medicine Metformin for diabetes type 2. Published July 07, 2020 Diabetes type 2 is the most common diabetes disease and a growing endemic disease across the world. It usually develops in adulthood and means that the body still produces insulin, but...